Xolremdi Disease Interactions
There are 3 disease interactions with Xolremdi (mavorixafor).
Mavorixafor (applies to Xolremdi) liver disease
Moderate Potential Hazard, Moderate plausibility.
Mavorixafor is not recommended in patients with moderate to severe liver dysfunction.
Mavorixafor (applies to Xolremdi) QTc prolongation
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Long QT Syndrome, Hypokalemia
Mavorixafor causes concentration-dependent QTc interval prolongation. Correct any modifiable risk factors for QTc prolongation (e.g., hypokalemia), assess QTc at baseline and monitor during treatment as clinically indicated.
Mavorixafor (applies to Xolremdi) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Mavorixafor is not recommended in patients with severe renal impairment and end stage renal disease.
Switch to professional interaction data
Xolremdi drug interactions
There are 623 drug interactions with Xolremdi (mavorixafor).
Xolremdi alcohol/food interactions
There is 1 alcohol/food interaction with Xolremdi (mavorixafor).
Report options
More about Xolremdi (mavorixafor)
- Xolremdi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: other immunostimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mozobil
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected ...
Plerixafor
Plerixafor is used for hematopoietic stem cell mobilization, multiple myeloma, non-hodgkin's lymphoma
Mavorixafor
Mavorixafor is used to treat WHIM syndrome (warts, hypogammaglobulinemia, infections, and ...
Glatiramer
Glatiramer acetate (brand name Copaxone, Glatopa, and generics) is used to treat relapsing forms of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
